查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466134

臨床試驗供應和物流市場：按服務、按類型、按階段、按治療領域、按最終用戶 - 2024-2030 年全球預測

Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗供應和物流市場規模預計為243.3億美元，預計2024年將達262億美元，2030年將達到410.4億美元，複合年成長率為7.75%。

臨床試驗供應和物流包括進行臨床試驗所需的臨床試驗材料 (CTM) 的規劃、管理、儲存和分發。這些材料包括臨床實驗藥品 (IMP)、安慰劑、病患套件、輔助用品、標籤服務等。 CTSL 的主要目標是按照良好生產規範 (GMP) 和良好分銷規範 (GDP) 有效地進行臨床試驗，同時保持產品品質和完整性。慢性病的流行以及政府對藥物研發過程的投資不斷增加正在推動臨床試驗用品和物流的使用。另一方面，臨床試驗的高昂成本和訓練有素的專家數量有限正在阻礙市場成長。然而，人們對藥物開發計劃的興趣日益濃厚，再加上臨床試驗的外包，預計未來幾年其使用量將會增加。

主要市場統計
基準年[2023] 243.3億美元
預測年份 [2024] 262億美元
預測年份 [2030] 410.4億美元
複合年成長率（%） 7.75%

低溫運輸配送服務不斷進步，服務需求增加

比較藥物採購是臨床試驗的一個重要方面，供應鏈管理公司從值得信賴和核准的供應商採購必要的藥物和其他材料，以及採購臨床實驗藥物和參考材料。此過程在不同地點和國家的臨床實驗期間維持標準供應。採購比較器有助於保持測試結果的一致性，同時避免因產品或其品質的變化而導致的潛在混淆。物流與配送管理臨床實驗藥物到不同地區多個研究地點的運輸與交付。這包括協調海關程序、監控每個國家的監管合規要求以及確保必要時的低溫運輸儲存。製造是指臨床試驗材料的製造，包括活性藥物成分（API）、賦形劑、藥品和安慰劑製劑。生產過程必須遵守監管機構制定的嚴格的良好生產規範 (GMP) 準則，以確保在整個測試期間始終生產出高品質的產品。包裝、標籤和致盲服務負責準備最終臨床試驗材料以運送到研究機構。包裝涉及根據特定方案要求創建單位劑量包裝或散裝包裝，同時在運輸過程中保持適當的環境條件。標籤涉及在包裝上列印準確的資訊，例如劑量、儲存說明、有效期限和唯一識別碼。盲法是指向試驗參與者、臨床實驗和現場工作人員隱藏治療分配的過程，以避免試驗結果中潛在的偏差。儲存和保存服務涵蓋臨床試驗材料整個生命週期的安全存儲，從最初到達儲存設施到最終銷毀，包括提供適當的溫度控制環境，這包括確保維護、遵守材料處理的監管指南、並限制授權負責人的訪問。

類型：小分子在製藥領域的使用快速增加

在臨床試驗供應和物流中，生物製藥、醫療設備和小分子提供了針對特定醫療需求和治療目標的獨特優勢。生物製藥（生物製藥）是透過活體生物體開發的，因其能夠精確靶向病變細胞而受到青睞。儘管需要複雜的製造和低溫運輸管理，我們仍為傳統治療方法不足以治療的疾病提供副作用最小的有效治療方法。醫療設備包括簡單的工具和複雜的系統，例如核磁共振造影系統，它們作為非侵入性診斷和治療選擇而受到青睞，行業領導者得到了物流公司的支持。小分子藥物的特徵是分子量小，易於滲透到細胞中，由於其多功能性和易於給藥而變得極為重要。生物製藥、設備或小分子之間的選擇取決於所解決的特定健康狀況、治療和研究目標以及物流考慮，這些因素可用於推進患者照護和臨床研究，需要強調的是，它們發揮著互補作用。

擴大三期臨床試驗的供應與物流服務範圍

生物有效性測試確定活性成分或治療化合物滲透作用部位並變得可用的速率和程度。生物等效性測試比較兩種藥物之間的生物利用度。這些測試對於學名藥的開發至關重要。第一階段臨床試驗是新藥首次應用於人體的試驗，通常由少數健康志願者進行。主要目的是評估安全性、耐受性、藥物動力學和動態。第二階段試驗將測試該藥物的有效性並繼續評估其安全性。研究族群通常包括患有所研究的病症或疾病的患者。第三階段試驗涉及大量患者，以確認藥物的有效性、監測副作用、與常用的治療方法進行比較，並收集安全使用藥物的資訊。第四階段（上市後監測）是藥物被核准向消費者銷售後的持續調查。它的目的是檢測罕見和長期的副作用，並比較常用藥物的有效性。

治療領域：擴大私營和公共部門在癌症領域的投資和研究活動

在處理血液樣本等敏感生物材料時，血液疾病臨床試驗用品和物流需要仔細協調。此類測試通常需要專門的儲存和及時的運輸，以確保樣品的完整性以獲得準確的測試結果。心血管疾病臨床實驗需要對臨床實驗藥物進行嚴格的控制和監測。鑑於這些疾病的高發病率，臨床實驗廣泛，需要可擴展的物流解決方案來有效管理臨床實驗成分的分配。由於臨床實驗藥物的敏感性，中樞神經系統和精神疾病領域的臨床試驗需要創新的物流解決方案。其中包括需要特殊處理、分配通訊協定和嚴格遵守法規的受管制物質。涉及皮膚病的臨床實驗通常需要多種劑型，包括外用和口服藥物，需要客製化的物流策略。快速且準確的物流對於維持這些產品在不同氣候和地區的有效性至關重要。消化器官系統疾病臨床實驗要求供應鏈善於處理從酵素到益生菌的各種臨床實驗藥物，並特別注意在不同的儲存條件下維持產品的穩定性和完整性。耳鼻喉科臨床試驗物流重點在於專業設備和藥物的分配，以確保及時運送到臨床試驗地點。遵守特定的儲存說明對於保持這些物品的有效性至關重要。免疫學測試通常涉及生技藥品的使用，這需要低溫運輸物流和先進的監控以防止劣化。此類臨床試驗的全球性使運輸變得複雜，並且需要強大的追蹤和溫度控制系統。由於感染疾病需要新的治療方法，特別是在大流行情況下，臨床實驗藥物供應物流的重點是快速擴充性和分配。此類治療藥物的安全、快速運輸機制對於在實驗室和臨床實驗試驗地點之間運輸敏感材料至關重要。

代謝疾病臨床試驗需要處理多種臨床實驗藥物，並且通常需要客製化的物流解決方案。注意運輸和儲存條件的細節對於確保這些化合物的完整性至關重要。劑量準確性和時間安排在腎臟相關試驗中至關重要，因此透過先進的追蹤和物流規劃來精確管理藥物和設備至關重要。腫瘤臨床試驗是最複雜的臨床試驗之一，通常需要針對個別患者進行高度專業化的治療。這需要靈活、快速的物流系統，能夠在惡劣的條件下處理包括活細胞在內的精緻材料。

此外，罕見疾病臨床試驗為供應鏈帶來了獨特的挑戰，因為患者數量通常有限且地理位置分散。客製化的物流解決方案對於滿足臨床試驗的獨特需求和緊急情況至關重要。此外，呼吸系統疾病臨床實驗需要物流系統容納各種臨床實驗藥物，包括吸入器和霧化器，確保精確的溫度控制和快速的通路，以確保交付時的產品功效。

最終用戶：製藥和生物技術公司更多地使用臨床試驗用品和物流

合約委外研發機構(CRO) 依靠臨床試驗供應和物流服務在臨床試驗的所有階段提供端到端支援。合作夥伴關係為 CRO 提供了一個靈活的供應鏈，以確保及時向臨床實驗試驗地點交付臨床實驗藥品 (IMP)、輔助材料和設備。此外，這些服務還幫助 CRO 在受控環境中管理對溫度敏感的貨運，並即時監控世界各地倉庫的存量基準。醫療設備製造商依靠臨床試驗供應和物流服務來有效管理複雜的供應鏈要求。透過利用專業物流提供者的專業知識，醫療設備製造商可以在運輸過程中保持適當的儲存條件，遵守進出口法規，並降低與全球器械分銷相關的風險。製藥和生物技術公司嚴重依賴臨床試驗供應和物流服務來滿足其臨床試驗需求。這些服務有助於管理臨床實驗生物藥品的整個供應鏈，包括製造、包裝、標籤、分銷、儲存和銷毀。由於生物製藥的脆弱性和脆弱性，製藥和生物技術公司需要專門的物流解決方案來保持產品在運輸過程中的穩定性。此外，這些服務還可以利用需求預測工具和實施準時制(JIT) 策略，幫助製藥和生物技術公司最佳化其供應鏈、最大限度地減少浪費並消除過剩庫存，並有助於降低與缺貨商品相關的價格。

區域洞察

在美洲地區，北美擁有重要的臨床試驗供應和物流，其中美國憑藉強大的製藥業和大量研發投資引領成長。此外，大量大型製藥企業進行臨床試驗以及政府對研發活動的大力支持正在支持市場擴張。由於南美洲不斷發展的醫療基礎設施和對臨床研究的日益關注，也促進了臨床試驗用品和物流的使用增加。由於中國、印度、韓國、台灣、印尼和越南等國家製藥業的快速發展，亞太地區臨床試驗用品和物流市場正在快速成長。此外，由於資源豐富且價格具競爭力，許多跨國製藥公司正在該地區建立研發中心或與當地合作夥伴合作。在EMEA（歐洲、中東和非洲）地區，歐洲由於擁有大量的製藥和生物技術公司，傳統上被認為是全球臨床試驗供應和物流市場的據點。歐盟 (EU) 已建立了在成員國之間進行臨床試驗的框架，以確保臨床實驗藥品 (IMP) 的安全性、有效性和品質。此外，中東和非洲是歐洲、中東和非洲地區的新興市場。其中包括政府增加醫療保健支出、跨國製藥公司開拓市場以擴大有資格獲得臨床實驗藥物和醫療設備的患者數量、醫療保健基礎設施的持續發展以及透過教育投資確保熟練的勞動力。

FPNV定位矩陣

FPNV 定位矩陣對於評估臨床試驗供應和物流市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對臨床試驗供應和物流市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.臨床試驗供應和物流市場的市場規模和預測是多少？

2.在臨床試驗供應和物流市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.臨床試驗供應和物流市場的技術趨勢和法規結構是什麼？

4.臨床試驗供應和物流市場主要供應商的市場佔有率是多少？

5. 進入臨床試驗供應及物流市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著慢性病發病率上升，政府增加資金以加強整個經濟領域的藥物研發活動
      • 臨床試驗的全球化與法規的統一
    • 抑制因素
      • 與技術整合和資料管理相關的問題
    • 機會
      • 整合人工智慧和機器學習以進行供應鏈最佳化中的預測分析
      • 藥廠和 CDMO 之間的合作活動增加
    • 任務
      • 與臨床試驗供應和物流業務相關的擔憂
  • 市場區隔分析
    • 服務：低溫運輸配送服務隨著需求的成長而不斷發展
    • 類型：小分子在醫藥領域的使用快速增加
    • 階段：擴大3期臨床試驗供應與物流服務範圍
    • 治療領域：私營和公共部門在腫瘤學方面的投資和研究活動激增
    • 最終用戶：製藥和生物技術公司更多地使用臨床試驗用品和物流
  • 市場趨勢分析
    • 整合美洲供應鏈強大的藥品生產能力和先進技術
    • 擴大醫療保健產業和政府支持措施加強全部區域亞太地區的臨床試驗物流
    • 市場參與者實力雄厚，並持續專注於發展全部區域的藥品供應鏈
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化
    • Catalent, Inc.：積極參與網路研討會和會議，推廣臨床試驗供應和物流方面的創新解決方案和服務。
    • Infosys Limited：專注於滲透定價策略，以低價提供解決方案，同時確保高精度和高品質
    • Almac 集團：Marken 發起新的行銷宣傳活動以促進臨床藥品的儲存和分銷
    • Eurofins Scientific Group：Eurofins Scientific Group 專注於會議和展覽，以實現有效的產品行銷。
    • Lonza Group AG：Lonza Group AG 加強全球擴張的關鍵數位行銷策略
    • 生物藥品：利用數位技術簡化供應鏈、提高透明度並改善與相關人員的溝通
    • 醫療設備：普及解決相關人員擔憂的教育內容
    • 小分子：解決激烈競爭和監管複雜性的需要
    • 臨床試驗供應及物流服務採取多元化行銷策略

第6章臨床試驗供應與物流市場：依服務分類

  • 比較採購
  • 物流/配送
  • 製造業
  • 包裝、標籤和致盲
  • 儲存和保留

第7章臨床試驗用品和物流市場：按類型

  • 生物製藥
  • 醫療設備
  • 小分子

第8章臨床試驗供應及物流市場分階段

  • 學士/工學士研究
  • 階段1
  • 階段2
  • 第三階段
  • 第四階段

第9章依治療領域分類的臨床試驗供應及物流市場

  • 血液疾病
  • 心血管疾病
  • 中樞神經系統和精神障礙
  • 皮膚病
  • 消化系統疾病
  • 耳鼻喉科疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 腎臟病學
  • 腫瘤學
  • 罕見疾病
  • 呼吸系統疾病

第10章臨床試驗供應與物流市場：依最終使用者分類

  • 合約調查機構
  • 醫療設備公司
  • 製藥和生物技術公司

第11章美洲臨床試驗供應及物流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太臨床試驗供應及物流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲臨床試驗供應及物流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • PCM Trials 收購荷蘭臨床試驗服務
    • Piramal Pharma Solutions 慶祝在蘇格蘭格蘭奇茅斯開設 ADC 製造廠
    • Biocare 宣布美國擴張作為全球成長策略的一部分
    • Vaxcyte 與 Lonza 簽署新的 PCV 商業製造協議
    • Piramal Pharma Solutions 在艾哈默德巴德的 Discovery Services 地點推出體外生物學功能
    • Signant Health 成立 Signant Biotech，以加速和簡化新興生物製藥公司的臨床開發
    • N-SIDE 推出革命性軟體 Lighthouse，塑造全球臨床試驗供應管理的未來
    • Zuellig Pharma 與 GSK 在新加坡建立疫苗分銷中心
    • Alyceum Therapeutics 與 Eurofins CDMO 簽署醫藥多計劃協議
    • Vial宣布與皇家國際集團建立策略夥伴關係
    • Biocair 與 TrakCel 合作提高供應鏈視覺性
    • IDEAYA 擴大與輝瑞的臨床試驗合作和供應協議
    • 康泰倫特開始斥資 2,000 萬美元擴建德國臨床供應設施
    • Eurofins Biopharma 產品測試 ENCO 擴大在美國的產能
    • Calyx推出新的臨床試驗供應預測服務
    • 康泰倫特完成新加坡臨床供應設施擴建，以提高溫度控制能力
    • PAREXEL 在中國蘇州開設臨床試驗用品和物流倉庫

第15章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-501246436315

[196 Pages Report] The Clinical Trial Supply & Logistics Market size was estimated at USD 24.33 billion in 2023 and expected to reach USD 26.20 billion in 2024, at a CAGR 7.75% to reach USD 41.04 billion by 2030.

Clinical trial supply & logistics encompasses the planning, management, storage, and distribution of clinical trial materials (CTMs) needed to conduct clinical studies. These materials include investigational medicinal products (IMPs), placebos, patient kits, ancillary supplies, and labeling services. The main objective of CTSL is to ensure that clinical trials are conducted efficiently and in compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines while maintaining product quality and integrity. The prevalence of chronic disorders and increasing government investments in pharmaceutical research & development process drives the use of clinical trial supply & logistics. On the contrary, the cost-intensive nature of clinical trials and the limited availability of trained professionals hinders market growth. However, growing interest in drug development projects coupled with outsourcing clinical trials is expected to increase its usage in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

Services: Continuous advancements in cold chain distribution services with growing demand

Comparator sourcing is a crucial aspect of clinical trials where supply chain management companies source the required drugs and other materials from reliable and approved sources, which involves procuring investigational and reference products. The process ensures that standardized supplies are maintained throughout the trial period across different sites and countries. Comparator sourcing helps maintain consistency in trial results while avoiding any potential disruptions due to variations in products or their quality. Logistics & distribution encompasses the management of transportation and delivery of clinical trial materials to multiple research sites across various regions. This includes coordinating with customs clearance procedures, monitoring regulatory compliance requirements for each country, and ensuring cold chain storage is maintained if necessary. Manufacturing refers to the production of clinical trial materials, including active pharmaceutical ingredients (APIs), excipients, drug products, and placebo formulations. Manufacturing processes must adhere to strict Good Manufacturing Practices (GMP) guidelines set by regulatory authorities to ensure high-quality products are produced consistently throughout the entire study period. Packaging, labeling, and blinding services deal with preparing the final clinical trial materials for shipment to research sites. Packaging involves creating unit dose packs or bulk packaging according to specific protocol requirements while maintaining appropriate environmental conditions during transport. Labeling includes printing accurate information on packages, such as dosage strength, storage instructions, expiry date(s), and unique identification codes. Blinding refers to the process of concealing treatment allocations from trial participants, investigators, and site staff to avoid any potential biases in the results. Storage & retention services cover the secure housing of clinical trial materials throughout their entire lifecycle, from initial arrival at storage facilities until final destruction, including maintaining appropriate temperature-controlled environments, adhering to regulatory guidelines on material handling, and ensuring that limited access is granted to authorized personnel.

Type: Surging utilization of small molecules in the pharmaceutical sector

In clinical trial supplies & logistics, biological drugs, medical devices, and small molecules present unique advantages tailored to specific medical needs and treatment objectives. Biologic drugs, or biopharmaceuticals, developed through living organisms, are preferred for their precise ability to target diseased cells. They offer effective treatments with minimal side effects for conditions where traditional therapies fall short despite their need for complex manufacturing and cold chain management. Medical devices include simple tools, advanced systems, such as MRI machines, favored for their non-invasive diagnostics and treatment options, with industry giants supported by logistic companies. Small molecules, characterized by their low molecular weight and ease of penetration into cells, are pivotal for their versatility and ease of administration. The selection among biologics, devices, or small molecules hinges on the specific health condition being addressed, the goals of treatment or research, and logistical considerations, highlighting the diverse and complementary roles they play in advancing patient care and clinical research.

Phase: Increasing scope of supply & logistics services in phase 3 clinical trials

Bioavailability studies determine the rate and extent to which the active ingredient or therapeutic compound is soaked and becomes available at the site of action. Bioequivalence studies compare the bioavailability between two pharmaceutical products. These studies are crucial in the development of generic drugs. Phase 1 trials are the initial infusion of a new drug into humans, typically conducted with a few healthy volunteers. The primary goal is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Phase 2 trials test the efficacy of a drug and continue to evaluate its safety. The study population typically includes patients with the condition or disease being studied. Phase 3 trials involve large groups of patients and aim to confirm a drug's efficacy, monitor side effects, compare it to typically used treatments, and gather information that allows the drug to be used safely. Phase 4, or post-marketing surveillance, involves the ongoing study of a drug after it has been approved for consumer sale. It aims to detect rare or long-term adverse effects and compare the drug's effectiveness in general use.

Therapeutic Area: Proliferating private and public sector investments and research activities in oncology

In clinical trial supply & logistics for blood disorders, meticulous coordination is essential to handle sensitive biological materials, such as blood samples. These trials often require specialized storage and timely transportation to ensure sample integrity for accurate trial outcomes. Supply chain management for cardiovascular disease trials necessitates rigorous control and monitoring of investigational medicinal products. Trials are extensive and require scalable logistics solutions to manage trial component distribution efficiently, considering the high prevalence of these diseases. Clinical trials in the CNS and mental disorder domain necessitate innovative logistic solutions owing to the sensitive nature of investigational drugs. These include controlled substances requiring specialized handling, distribution protocols, and stringent regulatory compliance. Trials involving dermatological disorders often necessitate diverse product forms, including topicals and orals, requiring customized logistics strategies. Quick and precise distribution is vital to maintain the efficacy of these products across various climates and regions. For digestive disorder trials, the supply chain should be adept at handling various investigational products, from enzymes to probiotics, with special attention to maintaining product stability and integrity under different storage conditions. Supply logistics for ENT disease trials focus on the distribution of specialized devices and medication, ensuring timely delivery to trial sites. It's crucial to adhere to specific storage instructions to preserve the effectiveness of these items. Immunology trials often involve biologics that require cold chain logistics and advanced monitoring to guard against degradation. The global nature of these trials adds complexity to shipping and requires robust systems for tracking and temperature management. Trial supply logistics are focused on rapid scalability and distribution with the need for new treatments in infectious diseases, especially in pandemic situations. Secure and quick transport mechanisms for such therapeutics are critical for moving sensitive materials between labs and trial sites.

Clinical trials for metabolic disorders require handling a broad spectrum of investigational products, often necessitating personalized logistics solutions. Attention to detail in shipping and storage conditions is paramount to ensure the integrity of these compounds. Given the importance of dose accuracy and timing in nephrology-related trials, ensuring the precise management of medications and devices with advanced tracking and logistical planning is essential. Oncology trials are among the most complex, requiring highly specialized treatments often tailored to individual patients. This necessitates a flexible and responsive logistics system that handles sensitive materials, including live cells, under strict conditions.

Moreover, clinical trials for rare diseases present unique supply chain challenges due to the often-limited patient population and scattered geographical distribution. Tailored logistics solutions are essential to address these trials' specific needs and urgency. Furthermore, in trials for respiratory disorders, logistical systems must accommodate a range of investigational products, including inhalers and nebulizers, requiring precise temperature control and swift distribution channels to ensure product efficacy upon delivery.

End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies

Contract research organizations (CROs) rely on clinical trial supply & logistics services to provide end-to-end support throughout all stages of clinical trials. Through partnerships, CROs can access flexible supply chains, ensuring timely delivery of investigational medicinal products (IMP), ancillary materials, and devices to trial sites. Moreover, these services help CROs manage temperature-sensitive shipments through controlled environments and monitor real-time inventory levels at depots worldwide. Medical device companies utilize clinical trial supply & logistics services to manage their complex supply chain requirements efficiently. Medical device companies can maintain proper storage conditions during transportation, adhere to import/export regulations, and reduce risks associated with global device distribution by leveraging specialized logistics providers' expertise. Pharmaceutical & biotechnology companies heavily depend on clinical trial supply & logistics services for their clinical trial needs, and these services assist in managing the entire supply chain of investigational biopharmaceutical products, including manufacturing, packaging, labeling, distribution, storage, and destruction. Pharmaceutical & biotechnology companies require specialized logistics solutions to maintain product stability during transportation owing to biopharmaceutical products' fragile and sensitive nature. Furthermore, these services help pharmaceutical & biotechnology companies optimize their supply chains by utilizing demand forecasting tools and implementing just-in-time (JIT) strategies to minimize wastage and reduce prices associated with overstocking or stockouts.

Regional Insights

In the Americas region, North America has considerable utilization of clinical trial supply & logistics, with the United States leading the growth with its robust pharmaceutical industry and extensive investment in research and development (R&D). Furthermore, numerous leading pharmaceutical companies conducting clinical trials and strong government support for R&D activities drive market expansion. South America also contributes to increasing clinical trial supply & logistics usage due to its developing healthcare infrastructure and growing focus on clinical research. The Asia-Pacific region's clinical trial supply & logistics market is growing rapidly due to its rapidly evolving pharmaceutical industry in China, India, South Korea, Taiwan, Indonesia, and Vietnam, among others. Moreover, many multinational pharmaceutical companies have established their R&D centers or collaborations with local partners in this region due to resource availability at competitive prices. Within the EMEA region, Europe has been traditionally considered a stronghold for the global clinical trial supply & logistics market due to the presence of numerous pharmaceutical and biotechnology companies. The European Union (EU) has a well-established framework for conducting clinical trials across its member states that ensures the safety, efficacy, and quality of investigational medicinal products (IMPs). In addition, Middle East & Africa are emerging markets within the EMEA region due to increasing healthcare expenditure by governments, expansion of multinational pharmaceutical companies into these markets to tap a larger patient pool for testing their investigational drugs/devices, continuous development of healthcare infrastructure and availability of skilled workforce due to their investments in education.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supply & Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supply & Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Comparator Sourcing
    • Logistics & Distribution
      • Cold Chain Distribution
      • Non-Cold Chain Distribution
    • Manufacturing
    • Packaging, Labeling, & Blinding
    • Storage & Retention
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small Molecules
  • Phase
    • BA/ BE studies
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Therapeutic Area
    • Blood Disorders
    • Cardiovascular Diseases
    • CNS & Mental Disorders
    • Dermatological Disorders
    • Digestive Disorders
    • ENT Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Nephrology
    • Oncology
    • Rare Diseases
    • Respiratory Disorders
  • End User
    • Contract Research Organisations
    • Medical Devices Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • Massachusetts
        • Minnesota
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supply & Logistics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supply & Logistics Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supply & Logistics Market?

4. What is the market share of the leading vendors in the Clinical Trial Supply & Logistics Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supply & Logistics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
      • 5.1.1.2. Globalization of clinical trials and harmonization of regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
      • 5.1.3.2. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.4. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.5. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Strong pharmaceutical production capability and integration of advanced technologies in the supply chain across the Americas
    • 5.3.2. Expanding healthcare sectors coupled with supportive government initiatives augmenting clinical trial logistics across APAC region
    • 5.3.3. Robust presence of market players and continuous focus on advancing pharmaceutical supply chain across EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization
    • 5.8.1. Catalent, Inc. : Active participation in webinars and conferences to promote innovative solutions and services in clinical trial supply and logistics
    • 5.8.2. Infosys Limited: Focus on penetration pricing strategy to provide solution at a low price while ensuring high precision and quality
    • 5.8.3. Almac Group: Launch of new marketing campaign by Marken Limited to promote clinical drug product storage and distribution
    • 5.8.4. Eurofins Scientific Group: Eurofins Scientific Group's focus on conferences and fairs for effective product marketing
    • 5.8.5. Lonza Group AG: Significant digital marketing strategies by Lonza Group AG to enhance their global reach
    • 5.8.6. Biologic Drugs: Utilisation of digital technologies to streamline the supply chain, enhance transparency, and improve communication with stakeholders
    • 5.8.7. Medical Devices: Disseminating educational content addressing stakeholders' pain points
    • 5.8.8. Small Molecules: Need to address intense competition and regulatory complexities
    • 5.8.9. Adoption of diverse marketing strategies for clinical trial supply & logistics services

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supply & Logistics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. PCM Trials acquires Netherlands-based Clinical Trial Service
    • 14.3.2. Piramal Pharma Solutions Commemorates Opening of its ADC Manufacturing Expansion in Grangemouth, Scotland
    • 14.3.3. Biocair Announces the U.S. Expansion as Part Of Global Growth Strategy
    • 14.3.4. Vaxcyte and Lonza Sign New Commercial Manufacturing Agreement for PCVs
    • 14.3.5. Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
    • 14.3.6. Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical Development for Emerging Biopharmaceutical Organizations
    • 14.3.7. N-SIDE Introduces Lighthouse, Innovative Software to Shape the Future of Worldwide Clinical Trial Supply Management
    • 14.3.8. Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
    • 14.3.9. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
    • 14.3.10. Vial Announces Strategic Partnership with Royale International Group
    • 14.3.11. Biocair Partners with TrakCel to Improve Visibility in the Supply Chain
    • 14.3.12. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
    • 14.3.13. Catalent Starts Construction of USD 20M Expansion at Clinical Supply Facility in Germany
    • 14.3.14. Eurofins BioPharma Product Testing ENCO Expands the U.S. Capabilities Footprint
    • 14.3.15. Calyx Introduces New Clinical Trial Supply Forecasting Service
    • 14.3.16. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
    • 14.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 268. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 270. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 279. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 282. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 283. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 292. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 293. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 294. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 295. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 298. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAP